| 846 |
Picoxystrobin
|
-
Picoxystrobin, CAS-RN: 117428-22-5, DTXSID9047542
|
587: Inhibition of the mitochondrial complex III of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 847 |
Muristerone A
|
|
342: Ecdysone receptor hyperactivation leading to mortality via mis-timed activation of nuclear receptor cascade
|
| 848 |
Cucurbitacin B
|
|
606: Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1
|
| 849 |
Cucurbitacin D
|
|
606: Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1
|
| 850 |
Deguelin
|
-
Deguelin, CAS-RN: 522-17-8, DTXSID10200231
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 851 |
Pyrimidifen
|
-
Pyrimidifen, CAS-RN: 105779-78-0, DTXSID9057925
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 852 |
Tebufenpyrad
|
-
Tebufenpyrad, CAS-RN: 119168-77-3, DTXSID0034223
|
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
|
| 853 |
Brusatol
|
|
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
|
| 854 |
ML385
|
|
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
|
| 855 |
Metribuzin
|
-
Metribuzin, CAS-RN: 21087-64-9, DTXSID6024204
|
567: Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition
|
| 856 |
Chlorotoluron
|
-
Chlorotoluron, CAS-RN: 15545-48-9, DTXSID8052853
|
567: Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition
|
| 857 |
Oxaliplatin
|
-
Oxaliplatin, CAS-RN: 61825-94-3, DTXSID0036760
|
472: DNA adduct formation leading to kidney failure
|
| 858 |
Carboplatin
|
-
Carboplatin, CAS-RN: 41575-94-4, DTXSID3046742
|
472: DNA adduct formation leading to kidney failure
|
| 865 |
5-Methylchrysene
|
-
5-Methylchrysene, CAS-RN: 3697-24-3, DTXSID6063143
|
644: Bulky DNA adducts leading to chromosomal aberrations and mutations
|
| 866 |
3-Methylcholanthrene
|
-
3-Methylcholanthrene, CAS-RN: 56-49-5, DTXSID0020862
|
644: Bulky DNA adducts leading to chromosomal aberrations and mutations
|
| 867 |
2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine
|
-
2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine, CAS-RN: 105650-23-5, DTXSID3037628
|
644: Bulky DNA adducts leading to chromosomal aberrations and mutations
|
| 875 |
17-Methyltestosterone
|
-
17-Methyltestosterone, CAS-RN: 58-18-4, DTXSID1033664
|
547: Androgen receptor agonism leading to long anogenital distance (AGD) in female offspring
|
| 876 |
Testosterone propionate
|
-
Testosterone propionate, CAS-RN: 57-85-2, DTXSID9036515
|
547: Androgen receptor agonism leading to long anogenital distance (AGD) in female offspring
|
| 877 |
Lomitapide
|
-
Lomitapide, CAS-RN: 182431-12-5, DTXSID50171294
|
653: Inhibition to Microsomal Triglyceride Transfer Protein Leads to Steatosis
|
| 10 |
Benzo(k)fluoranthene
|
-
Benzo(k)fluoranthene, CAS-RN: 207-08-9, DTXSID0023909
|
2 AOPs
|
| 11 |
Bis(2-ethylhexyl) phthalate
|
-
Di(2-ethylhexyl) phthalate, CAS-RN: 117-81-7, DTXSID5020607
|
2 AOPs
|
| 15 |
Diclofenac sodium
|
-
Diclofenac sodium, CAS-RN: 15307-79-6, DTXSID3037208
|
2 AOPs
|
| 32 |
Letrozole
|
-
Letrozole, CAS-RN: 112809-51-5, DTXSID4023202
-
Fadrozole, CAS-RN: 102676-47-1, DTXSID5034141
|
2 AOPs
|
| 34 |
Mercaptobenzothiazole
|
-
2-Mercaptobenzothiazole, CAS-RN: 149-30-4, DTXSID1020807
|
2 AOPs
|
| 35 |
Mercuric chloride
|
-
Mercuric chloride, CAS-RN: 7487-94-7, DTXSID5020811
|
2 AOPs
|